Verisante Technology, Inc. has entered into an exclusive agreement with Laserwelt to distribute Verisante Aura in Germany, Austria and Liechtenstein. Laserwelt has a showroom in downtown Berlin and currently distributes the world's top dermatological brands of medical devices for skin care treatments, in addition to other devices for use in dermatological practices for a variety of other medical applications. Aura(TM) is a complementary addition to the Company's existing product line.

Verisante Aura is indicated for use for the evaluation of skin lesions that may be clinically suspicious for melanoma, squamous cell carcinoma and/or basal cell carcinoma when a medical professional chooses to obtain additional information to rule out one of the above conditions before making a final decision to biopsy. Aura(TM) is a non-invasive optical system that uses Raman spectroscopy to biochemically analyze the skin, providing immediate results. The device will help to automate the current process of diagnosis, allowing rapid scanning of the 20 to 40 skin lesions on at-risk individuals, improving patient outcomes and comfort.